<DOC>
	<DOCNO>NCT01164332</DOCNO>
	<brief_summary>The disposition NRL972 15-second intravenous injection 2 mg NRL972 distinctly slow patient hepatic cirrhosis acute hepatitis healthy control subject . NRL972 appear suitable investigational marker hepatic transporter clearance dysfunction . Although pharmacokinetics NRL972 provide reliable differentiation subject group , approach relies precisely time sample venous blood , cautious preparation , handle on-site storage plasma sample , transfer sample central laboratory analysis , availability validate assay procedure . For reason , interest develop validate alternative method determine concentration NRL972 venous blood . Two method develop date , utility determine NRL972 pharmacokinetics yet establish .</brief_summary>
	<brief_title>Sensitivity Alternative NRL972 Detection Methods Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Subjects meet follow condition eligible enrolment : Males female ( female nonchildbearing potential childbearing potential take medically appropriate contraception ) Caucasian Age : 20 45 year BMI 20 26 kg.m2 Healthy base prestudy examination Suitable vein easy cannulation Willing able provide inform consent Subjects follow category exclude enrolment : General subject Previous participation trial Participant trial last 90 day Donation blood last 60 day history blood loss exceed 300 mL within last 3 month History clinically relevant allergy Presence acute chronic infection Presence history relevant comorbidity Resting systolic blood pressure &gt; 160 &lt; 90 mmHg , diastolic blood pressure &gt; 95 &lt; 50 mmHg Clinically relevant ECGabnormalities , prolong QTc &gt; 450 msec male &gt; 460 msec female particular Presence relevant abnormality laboratory safety test , especially low haemoglobin , increase liver enzymes Positive serology HBsAg , anti HBc anti HCV Positive HIV test Positive alcohol urine drug test recruitment History alcohol and/or drug abuse and/or daily use &gt; 30 g alcohol Smoking 10 cigarettes/day equivalent tobacco product Use prohibit medication Suspicion evidence subject trustworthy reliable Suspicion evidence subject able make free consent understand information regard General females Positive pregnancy test Lactating Not use appropriate contraception premenopausal woman</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>